Figure 1. IKKβ activity in myeloid cells is required for rejection of allogenic melanoma and CD8+ T cells are important in this rejection. Knockout of IKKβ in myeloid cells confers a protumor phenotype to immune cells with enhanced tumor growth. Constitutive activation of IKKβ (CA) in myeloid cells blocks melanoma tumor outgrowth.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
